This brand name is authorized in Nigeria.
The drug DURART contains one active pharmaceutical ingredient (API):
1
|
UNII
33O78XF0BW - DARUNAVIR ETHANOLATE
|
|
Darunavir is an inhibitor of the dimerisation and of the catalytic activity of the HIV-1 protease (KD of 4.5 × 10-12 M). It selectively inhibits the cleavage of HIV encoded Gag-Pol polyproteins in virus infected cells, thereby preventing the formation of mature infectious virus particles. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| C4-1775 | Tablet | Durart 800 mg Tablet TAB 800 mg 1 x 30's | Tablet | 03/08/2021 |
| C4-1776 | Tablet | Durart 600 mg Tablet TAB 600 mg 1 x 60's | Tablet | 03/08/2021 |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | C4-1775, C4-1776 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.